Jaguar Health, Inc. (NASDAQ:JAGX)

PRESS RELEASE

published on 03/31/2025 at 14:00, 10 months ago

Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023
Jaguar Health, Inc. reports a 20% increase in total net revenue for 2024, reaching $11.7 million. Expecting first results in Q2 2025 for crofelemer trials. FDA meeting scheduled for Phase 3 OnTarget trial

Financial Results Jaguar Health Net Revenue FDA Meeting POC Trials
BRIEF

published on 03/28/2025 at 14:05, 10 months 3 days ago

Jaguar Health Highlights Veterinary Support for Canalevia-CA1

FDA Approval Canalevia-CA1 Veterinary Oncology Dog Chemotherapy Non-Antimicrobial Treatment
BRIEF

published on 03/28/2025 at 14:05, 10 months 3 days ago

Jaguar Health souligne son soutien vétérinaire à Canalevia-CA1

Canalevia-CA1 Approbation De La FDA Oncologie Vétérinaire Chimiothérapie Canine Traitement Non Antimicrobien
PRESS RELEASE

published on 03/28/2025 at 14:00, 10 months 3 days ago

83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey
Jaguar Health's Canalevia-CA1 receives FDA approval for chemotherapy-induced diarrhea in dogs, addressing a critical unmet need in veterinary oncology

FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea Veterinary Oncology
BRIEF

published on 03/27/2025 at 13:35, 10 months 4 days ago

Jaguar Health Secures FDA Meeting to Discuss Crofelemer Results in Breast Cancer Trial

Crofelemer Jaguar Health Breast Cancer FDA Meeting OnTarget Study
BRIEF

published on 03/27/2025 at 13:35, 10 months 4 days ago

Jaguar Health obtient une réunion avec la FDA pour discuter des résultats de l'essai Crofelemer sur le cancer du sein

Crofelemer Jaguar Health Cancer Du Sein Réunion De La FDA Étude OnTarget
PRESS RELEASE

published on 03/27/2025 at 13:30, 10 months 4 days ago

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study
Napo Pharmaceuticals presents statistically significant responder analysis results for crofelemer in breast cancer patients at San Antonio Breast Cancer Symposium and MASCC, FDA Type C Meeting scheduled for 2025

Napo Pharmaceuticals Crofelemer Breast Cancer FDA Meeting Responder Analysis
BRIEF

published on 03/26/2025 at 16:05, 10 months 5 days ago

Jaguar Health participera à la conférence Emerging Growth et organisera un webcast pour les investisseurs.

Jaguar Health Conférence Sur La Croissance Émergente Webcast Pour Les Investisseurs Développement Crofelemer Résultats Financiers Du Quatrième Trimestre 2024
BRIEF

published on 03/26/2025 at 16:05, 10 months 5 days ago

Jaguar Health to Present at Emerging Growth Conference and Host Investor Webcast

Investor Webcast Jaguar Health Emerging Growth Conference Crofelemer Development Q4 2024 Financials
PRESS RELEASE

published on 03/26/2025 at 16:00, 10 months 5 days ago

Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts
Jaguar Health, Inc. announces virtual presentation and investor webcast dates. Company to file annual report on March 31, 2025. Lisa Conte to discuss upcoming developments

Virtual Presentation Investor Webcast Annual Report Lisa Conte Jaguar Health Inc.

Published on 01/31/2026 at 03:15, 16 hours 30 minutes ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 17 hours 25 minutes ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 18 hours 5 minutes ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 19 hours 45 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 20 hours 45 minutes ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 15:54, 3 hours 51 minutes ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 7 hours 20 minutes ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 17 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 21 hours 45 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 23 hours 35 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026

View all EQS

Published on 01/30/2026 at 18:40, 1 day 1 hour ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 1 day 1 hour ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 1 day 2 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 2 hours ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 1 day 11 hours ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News